Cubist Systematic Strategies, LLC G1 Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$2.1 - $4.83 $324,114 - $745,462	154,340 Added 719.77%	175,783 $759,000
Q4 2023 Feb 14, 2024	BUY	$1.12 - $3.73 $94 - $313	84 Added 0.39%	21,443 $65,000
Q3 2023 Nov 14, 2023	BUY	$1.22 - $2.67 $26,057 - $57,028	21,359 New	21,359 $30,000
Q1 2023 May 15, 2023	BUY	$2.57 - $8.16 $208,002 - $660,429	80,935 Added 110.37%	154,266 $413,000
Q4 2022 Feb 14, 2023	SELL	$5.19 - $13.5 $1.93 Million - $5.02 Million	-371,510 Reduced 83.52%	73,331 $398,000
Q3 2022 Nov 14, 2022	BUY	$5.17 - $16.99 $966,422 - $3.18 Million	186,929 Added 72.48%	444,841 $5.56 Million
Q2 2022 Aug 15, 2022	BUY	$4.04 - $8.51 $498,317 - $1.05 Million	123,346 Added 91.66%	257,912 $1.27 Million
Q1 2022 May 16, 2022	BUY	$7.6 - $11.02 $1.02 Million - $1.48 Million	134,566 New	134,566 $1.02 Million
Q4 2021 Feb 14, 2022	SELL	$10.16 - $16.17 $280,009 - $445,645	-27,560 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$13.16 - $22.47 $291,507 - $497,732	22,151 Added 409.52%	27,560 $370,000
Q2 2021 Aug 16, 2021	SELL	$19.57 - $26.32 $117,987 - $158,683	-6,029 Reduced 52.71%	5,409 $119,000
Q1 2021 May 17, 2021	BUY	$17.58 - $32.59 $21,553 - $39,955	1,226 Added 12.01%	11,438 $275,000
Q4 2020 Feb 16, 2021	SELL	$10.99 - $20.4 $23,419 - $43,472	-2,131 Reduced 17.26%	10,212 $184,000
Q3 2020 Nov 16, 2020	BUY	$11.55 - $23.75 $139,420 - $286,686	12,071 Added 4437.87%	12,343 $143,000
Q2 2020 Aug 14, 2020	SELL	$9.57 - $24.37 $254,791 - $648,826	-26,624 Reduced 98.99%	272 $7,000
Q1 2020 May 15, 2020	BUY	$9.07 - $26.32 $137,201 - $398,142	15,127 Added 128.53%	26,896 $296,000
Q4 2019 Feb 14, 2020	BUY	$20.54 - $31.0 $241,735 - $364,839	11,769 New	11,769 $311,000
Q3 2019 Nov 14, 2019	SELL	$22.78 - $40.58 $203,767 - $362,988	-8,945 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$16.03 - $31.1 $483,160 - $937,385	-30,141 Reduced 77.11%	8,945 $274,000
Q1 2019 May 15, 2019	BUY	$14.4 - $21.45 $191,592 - $285,392	13,305 Added 51.61%	39,086 $649,000
Q4 2018 Feb 14, 2019	BUY	$16.51 - $51.33 $338,504 - $1.05 Million	20,503 Added 388.46%	25,781 $494,000
Q3 2018 Nov 14, 2018	BUY	$43.15 - $67.97 $227,745 - $358,745	5,278 New	5,278 $276,000
Q2 2018 Aug 14, 2018	SELL	$35.06 - $51.17 $97,957 - $142,968	-2,794 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$19.05 - $41.76 $44,119 - $96,716	2,316 Added 484.52%	2,794 $104,000
Q4 2017 Feb 14, 2018	BUY	$19.01 - $26.2 $9,086 - $12,523	478	478 $9,000

Others Institutions Holding GTHX

# of Institutions

Shares Held

3.55M

Call Options Held

11.7K

Put Options Held

View Full List

About G1 Therapeutics, Inc.

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

More about GTHX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account